| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Magenta Therapeutics Inc (NASDAQ: MGTA)
MGTA Technical Analysis
5
| As on 9th Jun 2023 MGTA SHARE Price closed @ 0.70 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 2.20 & Strong Sell for SHORT-TERM with Stoploss of 3.78 we also expect STOCK to react on Following IMPORTANT LEVELS. |
MGTASHARE Price
| Open | 0.70 | Change | Price | % |
| High | 0.72 | 1 Day | -0.02 | -2.78 |
| Low | 0.70 | 1 Week | 0.06 | 9.38 |
| Close | 0.70 | 1 Month | -0.08 | -10.26 |
| Volume | 17496 | 1 Year | -4.14 | -85.54 |
| 52 Week High 5.23 | 52 Week Low 0.36 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| MGTA Daily Charts |
MGTA Intraday Charts |
Whats New @ Bazaartrend |
MGTA Free Analysis |
|
|
MGTA Important Levels Intraday
| RESISTANCE | 0.74 |
| RESISTANCE | 0.73 |
| RESISTANCE | 0.72 |
| RESISTANCE | 0.71 |
| SUPPORT | 0.69 |
| SUPPORT | 0.68 |
| SUPPORT | 0.67 |
| SUPPORT | 0.66 |
MGTA Forecast April 2024
| 4th UP Forecast | 5.73 |
| 3rd UP Forecast | 4.12 |
| 2nd UP Forecast | 3.12 |
| 1st UP Forecast | 2.12 |
| 1st DOWN Forecast | -0.72 |
| 2nd DOWN Forecast | -1.72 |
| 3rd DOWN Forecast | -2.72 |
| 4th DOWN Forecast | -4.33 |
MGTA Weekly Forecast
| 4th UP Forecast | 2.24 |
| 3rd UP Forecast | 1.75 |
| 2nd UP Forecast | 1.44 |
| 1st UP Forecast | 1.14 |
| 1st DOWN Forecast | 0.26 |
| 2nd DOWN Forecast | -0.04 |
| 3rd DOWN Forecast | -0.35 |
| 4th DOWN Forecast | -0.84 |
MGTA Forecast2024
| 4th UP Forecast | 10.66 |
| 3rd UP Forecast | 7.47 |
| 2nd UP Forecast | 5.49 |
| 1st UP Forecast | 3.52 |
| 1st DOWN Forecast | -2.12 |
| 2nd DOWN Forecast | -4.09 |
| 3rd DOWN Forecast | -6.07 |
| 4th DOWN Forecast | -9.26 |
Magenta Therapeutics Inc ( NASDAQ USA Symbol : MGTA )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
MGTA Business Profile
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops novel medicines to bring the curative power of stem cell transplant, gene therapy, genome editing, and cell therapy to patients. The company is developing C100 and C300 targeted antibody-drug conjugates for transplant conditioning; MGTA-145, a stem cell mobilization product candidate to control stem cell mobilization; MGTA-456, an allogeneic stem cell therapy to control stem cell growth; E478, a small molecule aryl hydrocarbon receptor antagonist for the expansion of gene-modified stem cells; and G100, an antibody-drug conjugate program to prevent prophylaxis of graft-versus-host diseases. It has a has a research and clinical collaboration agreement with AVROBIO, Inc.to evaluate potential utility of MGTA-117 for conditioning of patients receiving one or more investigational lentiviral gene therapies; and clinical trial collaboration with bluebird bio, Inc. to evaluate the utility of MGTA-145, in combination with plerixafor, for mobilization and collection of stem cells in adults and adolescents with sickle cell disease. The company was formerly known as HSCTCo Therapeutics, Inc. and changed its name to Magenta Therapeutics, Inc. in February 2016. Magenta Therapeutics, Inc. was incorporated in 2015 and is headquartered in Cambridge, Massachusetts. Address: 100 Technology Square, Cambridge, MA, United States, 02139
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service